Aditi Pai
A little over a year ago, Nike made headlines when it announced that it was not working an Android app for its Nike+ FuelBand users.
A little over a year after completing a pilot study, pharmaceutical company AstraZeneca and Exco InTouch have launched a mobile-enabled program in the UK to help patients manage their chronic obstructive pulmonary disease (COPD), called Me&MyCOPD.
The program has three components -- a portal in which patients can connect with providers, a server on which information is saved and messages are schedules, and an app that the patient can use. Patients can use the program to track their condition, add data from medical devices, manage clinic visits, and view information on how to deal with different lifestyle issues.
“Me&MyCOPD will help patients to better control their condition and healthcare providers to make more informed decisions, tailoring care pathways to each patient’s individual needs," Exco InTouch Director of Product Strategy Mark Brincat said in a statement. "This translates into improving patient welfare and their quality of life by reducing the number of unplanned hospital admissions and the frequency and severity of exacerbations, decreasing the overall treatment costs at the same time.”
The program will use this data to better understand what patients need and to give them personal goals and management tools to better handle their condition. Because physicians will have real-time access to patients’ data, they will also be able to monitor the patient's adherence to treatment regimens and reach out to the patient if their condition worsens.
The pilot, which was completed in the UK in March 2013, was administered through several National Health Service Clinical Commissioning Groups and funded by AstraZeneca, with Exco InTouch providing the technology and outreach to providers. In the trial, patients also used a Bluetooth-enabled inhaler, offered by AstraZeneca, that automatically reported data to the app.
WebMD updated its consumer-facing health app this week: it now integrates a user's biometric data from certain activity trackers, wireless scales, and glucose meters.
Four months after pregnancy tracking app developer Wildflower Health launched a program for Wyoming Medicaid beneficiaries, the startup reported that nearly 70 percent of enrollees are using the app's main features.
Activity tracker shipments reached 2.
This week, a bevy of telehealth stakeholders sent incoming HHS secretary Sylvia Burwell a letter as part of ongoing efforts to improve the legal and political climate for telehealth.
HypoMap, a tool created by Glooko in partnership with Joslin
Boston-based Joslin Diabetes Center has created a new non-profit division, called Joslin Institute for Technology Translation (JITT), so that the healthcare organization can collaborate with companies currently developing tools for people with diabetes, according to a press release.
Around 11 percent of smokers who participated in a texting-based smoking cessation intervention program were able to abstain from using cigarettes six months after the start of the program, while only 5 percent of smokers in the control group were able to do so, according to a study of 503 people published in the American Journal of Preventive Medicine.
Venture funding for biosensing wearables, reached $282 million in 2013, five times what it was in 2011, according to a recent report and webinar from Rock Health.
Startups that came out of Dallas-based health accelerator Health Wildcatters' first class in August 2013 have so far raised almost $5 million in VC funding.